Cue Biopharma, Inc. (CUE): Depreciation & Amortization
$958.0K
Year ended 2025-12-31
$1.36M
Trailing 12 months to 2026-06-30
+1.3%
3-year compound annual growth
-2.0%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $958.0K | +141.3% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | $397.0K | -28.6% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | $556.0K | -39.7% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $922.0K | -26.7% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $1.26M | +18.9% | 2023-03-21, From 2021-01-01 |
| 2020-12-31 | $1.06M | +30.4% | 2022-03-16, From 2020-01-01 |
| 2019-12-31 | $810.8K | +6.7% | 2021-03-09, From 2019-01-01 |
| 2018-12-31 | $760.0K | n/a | 2020-03-12, From 2018-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | $958.0K | +141.3% |
| Celularity Inc (CELU) | 2025-12-31 | $7.29M | -7.9% |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $3.33M | +6.8% |
| Alumis Inc. (ALMS) | 2025-12-31 | $3.50M | +10.9% |
| NewAmsterdam Pharma Co N.V. (NAMS) | 2025-12-31 | $220.0K | +94.7% |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | $1.62M | +29.8% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $284.4K | +427.1% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $332.1K | +48.6% |
| CASI Pharmaceuticals, Inc. (CASIF) | 2025-12-31 | $1.20M | -7.7% |
Compare CUE, CELU, FHTX, ALMS side by side · Screen every company in Pharmaceutical Preparations ↗